Literature DB >> 18314871

Association of PIP5K2A with schizophrenia: a study in an indonesian family sample.

L Saggers-Gray1, H Heriani, H Y Handoko, I Irmansyah, A A A A Kusumawardhani, I Widyawati, N Amir, M W S Nasrun, S G Schwab, D B Wildenauer.   

Abstract

PIP5K2A variants have been shown to be associated with schizophrenia in Caucasian populations. This study tested 12 PIP5K2A SNPs for association with schizophrenia in a sample of 152 sib-pair families of Indonesian descent. All SNPs had previously been tested for association with schizophrenia in a German family sample by Schwab et al. [2006; Mol Psychiatry] and seven SNPs were nominally associated with schizophrenia in this previous study. The purpose of the study was to examine whether previously implicated PIP5K2A variants influence susceptibility to schizophrenia in populations of non-European descent. No single markers showed nominal association with schizophrenia in this Indonesian family sample, however multi-marker haplotypes including a previously associated exonic SNP marker revealed nominally significant association (P = 0.03). Power to detect association was greater than 80% for all previously implicated variants except for rs11013052, where power was greatly reduced due to the low minor allele frequency of this marker in the Indonesian sample. An explorative study combining the results of this study with those of our previous study indicated that rs11013052 was significantly associated with schizophrenia in the combined sample (P = 0.002). The results of this study suggest that any contribution of previously implicated DNA variants within the PIP5K2A gene to schizophrenia susceptibility in the Indonesian population is only minor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18314871     DOI: 10.1002/ajmg.b.30736

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  4 in total

1.  Association study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia.

Authors:  Olga Yu Fedorenko; Anton J M Loonen; Florian Lang; Valentina A Toshchakova; Evgenia G Boyarko; Arkadiy V Semke; Nikolay A Bokhan; Nikolay V Govorin; Lyubomir I Aftanas; Svetlana A Ivanova
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-28       Impact factor: 5.176

2.  Genetic variations of PIP4K2A confer vulnerability to poor antipsychotic response in severely ill schizophrenia patients.

Authors:  Harpreet Kaur; Ajay Jajodia; Sandeep Grover; Ruchi Baghel; Meenal Gupta; Sanjeev Jain; Ritushree Kukreti
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

3.  Genetic polymorphisms of PIP5K2A and course of schizophrenia.

Authors:  Evgeniya G Poltavskaya; Olga Yu Fedorenko; Natalya M Vyalova; Elena G Kornetova; Nikolay A Bokhan; Anton J M Loonen; Svetlana A Ivanova
Journal:  BMC Med Genet       Date:  2020-10-22       Impact factor: 2.103

4.  NRG1, PIP4K2A, and HTR2C as Potential Candidate Biomarker Genes for Several Clinical Subphenotypes of Depression and Bipolar Disorder.

Authors:  Anastasia Levchenko; Natalia M Vyalova; Timur Nurgaliev; Ivan V Pozhidaev; German G Simutkin; Nikolay A Bokhan; Svetlana A Ivanova
Journal:  Front Genet       Date:  2020-08-25       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.